Participant
Taylor Olson Adkins Sralla & Elam LLP
Paid on 2 local government issues in BRB's local issuance fee table, $21,125 in fees reported.
By role
| Role? | Issues? | Par of those issues? | Fees paid? | Median cost per $1,000? | Negotiated? | Competitive? | Private placement? | First FY? | Last FY? | Paid by the underwriter? |
|---|---|---|---|---|---|---|---|---|---|---|
| RoleOther counsel | Issues1 | Par of those issues$7,790,000 | Fees paid$15,000 | Median cost per $1,000$1.93 | Negotiated1 | Competitive0 | Private placement0 | First FY2022 | Last FY2022 | Paid by the underwriter$0 |
Issues
2 issues, newest first.
Skip the issues taylor olson adkins sralla & elam llp worked on table| Issue? | Issuer? | Closed? | FY? | Role? | Sale type? | Par? | Fees to this firm? | Per $1,000 of par? |
|---|---|---|---|---|---|---|---|---|
| Spec Assessment Rev Bonds Ser 2025 (City of Boyd PID 1 Impr Area 2 Proj & Impr Area 3 Proj) | Boyd | 5/29/2025 | 2025 | Other costs | Negotiated | $10,486,000 | $6,125 | $0.58 |
| Rev Bonds Ser 2022 | Heart of Texas Regional MHMR Center | 5/17/2022 | 2022 | Other counsel | Negotiated | $7,790,000 | $15,000 | $1.93 |
| Total, all 2 | $21,125 |
Spec Assessment Rev Bonds Ser 2025 (City of Boyd PID 1 Impr Area 2 Proj & Impr Area 3 Proj)
- Closed
- 5/29/2025
- FY
- 2025
- Role
- Other costs
- Sale type
- Negotiated
- Par
- $10,486,000
- Fees to this firm
- $6,125
- Per $1,000 of par
- $0.58
- Closed
- 5/17/2022
- FY
- 2022
- Role
- Other counsel
- Sale type
- Negotiated
- Par
- $7,790,000
- Fees to this firm
- $15,000
- Per $1,000 of par
- $1.93
Rows 1–2 of 2
Fees are as BRB's table reports them for each issue. The underwriter's spread counts once, and median and per-$1,000 figures use the issuer's one-time costs only: rows paid by the underwriter are shown in the fees but not added to them (how the participant tables are made).
EMMA links are added as each issue is matched.
Source: Local Issuance Fee By Year (updated by the publisher 10/6/2026). Loaded here 10/9/2026.
Texas fiscal years run September 1 to August 31.
Issuer names are shown as published, without source footnote letters.
Figures are as reported to the agency and have not been independently verified.